In a business war context, the Swiss pharmaceutical group Roche announces a massive investment of $ 50 billion in the United States over five years. Objective: to consolidate its presence on its main market and to avoid future customs surcharge.
In a business war context, the Swiss pharmaceutical group Roche announces a massive investment of $ 50 billion in the United States over five years. Objective: to consolidate its presence on its main market and to avoid future customs surcharge.